Non-consolidated Financial Results for the Three Months Ended March 31, 2024

On May 10, 2024 Oncolys BioPharma reported non-consolidated Financial Results for the Three Months Ended March 31, 2024 (Press release, Oncolys BioPharma, MAY 10, 2024, View Source [SID1234644739]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!